← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.92 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.91 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene (TREM2) — 0.91 Nutrient-Sensing Epigenetic Circuit Reactivation (SIRT1) — 0.91 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 0.90 CSF1R Inhibition-Mediated Microglial Replacement as a State (CSF1R) — 0.90 Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 0.90 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.90 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from (TREM2) — 0.89
Add
|
× Astrocyte C3aR Signaling × CD8+ T-Cell Perforin Path
C3, C3aR, NFKB1, PPARGC1A · Alzheimer's disease, Parkinson's disease · mechanistic
Composite 0.750
Price $0.50
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate starts from the claim that modulating C3, C3aR, NFKB1, PPARGC1A within the disease context of Alzheimer's disease, Parkinson's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate starts from the claim that modulating C3, C3aR, NFKB1, PPARGC1A within the disease context of Alzheimer's disease, Parkin
GZMB, PRF1, HLA-E, NKG2D · Alzheimer's disease, Parkinson's disease · mechanistic
Composite 0.710
Price $0.50
Evidence For 0
Evidence Against 0
## Mechanistic Overview
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss starts from the claim that modulating GZMB, PRF1, HLA-E, NKG2D within the disease context of Alzheimer's disease, Parkinson's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid Loss starts from the claim that modulating GZMB, PRF1, HLA-E, NKG2D within the disease context of Alzheimer's disease, Pa
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Adaptive Immunity Astrocyte Reactivity Alzheimer's disease Parkinson's disease
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 7/11
dimensions won
Astrocyte C3aR Signaling as Bifurcation
5/11
dimensions won
CD8+ T-Cell Perforin Pathway as Driver o
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Astrocyte C3aR Signaling as Bi CD8+ T-Cell Perforin Pathway a Mechanistic 0.700 0.700 Evidence 0.750 0.710 Novelty 0.500 0.500 Feasibility 0.500 0.500 Impact 0.500 0.500 Druggability 0.000 0.000 Safety 0.000 0.000 Competition 0.000 0.000 Data 0.000 0.000 Reproducible 0.710 0.680 KG Connect 0.500 0.500
Evidence Astrocyte C3aR Signaling as Bifurcation Point for A1/A2 Fate No evidence citations yet
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid L No evidence citations yet
Price History Overlay